Proposals for the 2020-2021 cycle are due by Friday, February 14, 2020.
The objective of the University of Michigan Coulter Translational Research Partnership Program (Coulter Program) is to bring medical innovations into healthcare through a commercial entity. As such, projects funded through Coulter will need to demonstrate:
- Clearly envisioned medical product concepts with high potential for healthcare impact
- Scientific merit leading up to the proposed translational research proposal
- Translational research plans to de-risk key technical hurdles and address commercial questions
- Strength and expertise of the interdisciplinary faculty partnership
- Industry or investor interest
- Clear path to company formation with angel or venture capital funding or to direct licensing of technology IP by a medical device, pharmaceutical, or diagnostics company who completes development and commercialization of the envisioned product
Proposals demonstrating the ability to meet these objectives will receive greater consideration for funding.
It is strongly suggested that applicants discuss their proposal with the Coulter Program Director Thomas Marten (email@example.com; (734) 647-1680) prior to submission to explore the commercial potential for your project and fit for Coulter funding opportunities.
Please see the Eligibility page for more information.
Application Review Process
Please see the Timeline page for more information.
Funding Submission Packet
Application materials are available on Competition Space, and can be downloaded here: https://umichcoulter.infoready4.com/
Details for Application Materials:
- Proposal (4 pages, 10 pt. font minimum)
- Please follow the template for the research proposal which can be downloaded on Competition Space: https://umichcoulter.infoready4.com/
- Budget (.xlsx format)
- Please follow the budget template and submit the budget as an excel spreadsheet. The template can be downloaded on Competition Space: http://umichcoulter.infoready4.com/
- Projects are funded for 1-year time periods at ~$100,000
- Requests for larger amounts should be discussed with Thomas Marten, Coulter Program Director (CPD).
- Seed grants ≤ $25,000 will be considered for projects requiring finite achievements (i.e. generation of data or a prototype necessary to apply for subsequent translational funding).
- Funds may not be used for construction or renovation.
- Allowable budget expenditures include: salary and fringe benefits for project personnel, materials and supplies, and pre-negotiated travel. Salary requests need to be justified based upon effort.
- The purchase of small equipment must be pre-negotiated with the CPD.
- Purchase of large, capital equipment is prohibited.
- Budget line items for outside consultants (i.e. regulatory assessment, market research and prototype manufacturing) are allowable, but will be managed through the Coulter CPD short code.
- The clinical co-PI must be included in the budget and his/her budget percentage MAY be cost-shared with the clinical department. Typically, 0% to 10% of a clinical collaborator’s salary is budgeted, with half of that amount cost-shared with the clinical department.
- Combined co-PI salaries and benefits should not exceed 20% of the total project budget and must adhere to the NIH salary cap
- Tuition for graduate students is allowable based on graduate student effort level on the project. Large tuition line items on budgets are discouraged. See budget template for additional details. Proposals will need to name specific graduate students, demonstrate how they will be active contributors on the project, and how their backgrounds are a fit for the project.
- A department signature is required on the bottom of the budget for any cost share commitment.
- References/Literature cited
- References/Literature cited should be included as supplemental material in a separate document.
- NIH-style Biosketches
- Biosketches for PIs and key personnel involved in the project should be included as supplemental material in a separate document.